Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 23, 2014 - Issue 6
Submit an article Journal homepage
1,461
Views
33
CrossRef citations to date
0
Altmetric
Drug Evaluations

Empagliflozin, a sodium glucose co-transporter 2 inhibitor, in the treatment of type 1 diabetes

Elizabeth M LamosUniversity of Maryland School of Medicine, 660 West Redwood Street, Howard Hall 469, Baltimore, MD 21201, USA
, MD,
Lisa M YounkUniversity of Maryland School of Medicine, Department of Medicine, 3-013 Bressler Research Building, 655 W. Baltimore St., Baltimore, MD 21201, USA
, BS &
Stephen N DavisUniversity of Maryland School of Medicine, Department of Medicine, 3-013 Bressler Research Building, 655 W. Baltimore St., Baltimore, MD 21201, USA;University of Maryland School of Medicine, 22 South Greene St. N3W42, Baltimore, MD 21201, USA+1 410 328 2488; +1 410 328 8688; [email protected]
, MBBS FRCP FACP
Pages 875-882 | Published online: 19 Apr 2014

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.